Tharimmune shares are trading lower after the company announced pricing of a $10 million public offering.
Portfolio Pulse from Benzinga Newsdesk
Tharimmune shares have dropped following the announcement of a $10 million public offering. The offering is likely dilutive to existing shareholders, causing the stock price to decrease.
November 28, 2023 | 3:43 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tharimmune's stock price is expected to face downward pressure in the short term due to the dilutive effect of the $10 million public offering.
Public offerings often lead to dilution of existing shares, which can result in a decrease in stock price as the market absorbs the additional share supply. Given the size of the offering relative to the company, this is likely to have a significant impact on Tharimmune's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100